Correlates of urokinase-type plasminogen activator in colorectal cancer: Positive relationship with nm23 and c-erbB-2 protein expression

Oncology Research

Volumn 10, Issue 1, 1998, Pages 47-54

  Berney, Christophe R ^a,b   Yang, Jia Lin ^a   Fisher, Richard J ^a   Russell, Pamela J ^a   Crowe, Philip J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Colorectal cancer; Immunohistochemistry; Metastasis; u PA; Video image analysis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; MONOMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; NUCLEOSIDE DIPHOSPHATE KINASE; NUCLEOSIDE DIPHOSPHATE KINASE A; TRANSCRIPTION FACTOR; TUMOR MARKER; UROKINASE;

ARTICLE; BIOSYNTHESIS; CANCER STAGING; COLORECTAL TUMOR; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; HUMAN; LIVER TUMOR; METABOLISM; METASTASIS; MORTALITY; NONPARAMETRIC TEST; PATHOLOGY; PREDICTION AND FORECASTING; RETROSPECTIVE STUDY; SURVIVAL RATE; TIME; TREATMENT OUTCOME;

COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; HUMANS; LIVER NEOPLASMS; MONOMERIC GTP-BINDING PROTEINS; NEOPLASM STAGING; NUCLEOSIDE-DIPHOSPHATE KINASE; PREDICTIVE VALUE OF TESTS; RECEPTOR, ERBB-2; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TIME FACTORS; TRANSCRIPTION FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; URINARY PLASMINOGEN ACTIVATOR;

EID: 0031610023     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Tryggvason, K.; Hoyhtya, M.; Salo, T. Proteoloytic degradation of extracellular matrix in tumor invasion. Biochim. Biophys. Acta 907:191-217; 1987.
2. Verspaget, H. W.; Sier, C. F. M.; Ganesh, S.; Griffioen, G.; Lamers, C. B. H. W. Prognostic value of plasminogen activators and their inhibitors in colorectal cancer. Eur. J. Cancer. 31A:1105-1109; 1995.
3. Jessup, J. M. Role of urokinase, its receptor, and serpins in colorectal carcinoma. Gastroenterology 107:1555-1559; 1994.
4. Sier, C. F. M.; Vloedgraven, H. J. M.; Ganesh, S.; Griffioen, G.; Quax, P. H. A.; Verheijen, J. H.; Dooijewaard, G.; Welvaart, K.; Van de Velde, C. J. H.; Lamers, C. B. H. W.; Verspaget, H. W. Inactive urokinase and increased levels of its inhibitor type 1 in colorectal cancer liver metastasis. Gastroenterology 107:1449-1456; 1994.
5. Ossowski, L.; Reich. E. Antibodies to plasminogen activator inhibit human tumor metastasis. Cell 35:611-619; 1983.
6. Grondahl-Hansen, J.; Ralfkiaer, E.; Kirkeby, L. T.; Kristensen, P.; Lund, L. R.; Dano, K. Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans. Am. J. Pathol. 138:111-117; 1991.
7. Markus, G.; Camiolo, S. M.; Kohga, S.; Madeja, J. M.; Mittelman, A. Plasminogen activator secretion of human tumors in short-term organ culture, including a comparison of primary and metastatic colon tumors. Cancer Res. 43:5517-5525; 1983.
8. Kohga, S.; Harvey, S. R.; Weaver, R. M.; Markus. G. Localization of plasminogen activators in human colon cancer by immunoperoxidase staining. Cancer Res. 45:1787-1796; 1985.
9. Sato, T.; Nishimura, G.; Yonemura, Y.; Nojima, N.; Ninomiya, I.; Fujimura, T.; Sugiyama, K.; Miwa, K.; Miyazaki, I.; Nonomura, A.; Yamaguchi, Y. Association of immunohistochemical detection of urokinase-type plasminogen activator with metastasis and prognosis in colorectal cancer. Oncology 52:347-352; 1995.
10. Mulcahy, H. E.; Duffy, M. J.; Gibbons. D.; McCarthy, P.; Parfrey, N. A.; O'Donoghue, D. P.; Sheahan, K. Urokinase-type plasminogen activator and outcome in Dukes' B colorectal cancer. Lancet 344:583-584; 1994.
11. Sier, C. F. M.; Quax, P. H. A.; Vloedgraven, H. J. M.; Verheijen, J. H.; Griffioen, G.; Ganesh, S.; Lamers, C. B. H. W.; Verspaget, H. W. Increased urokinase receptor levels in human gastrointestinal neoplasia and related liver metastases. Invas. Metast. 13:277-288; 1993.
12. Pyke, C.; Kristensen, P.; Ralfkiaer, E.; Grondahl-Hansen, J.; Eriksen, J.; Blasi, F.; Dano, K. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Am. J. Pathol. 138:1059-1067; 1991.
13. Burtin, P.; Chavanel, G.; Andre-Bougaran, J.; Gentile, A. The plasmin system in human adenocarcinomas and their metastases. A comparative immunofluorescence study. Int. J. Cancer 39:170-178; 1987.
14. Crowley, C. W.; Cohen, R. L.; Lucas, B. K.; Liu, G.; Shuman, M. A.; Levinson, A. D. Prevention of metastasis by inhibition of the urokinase receptor. Proc. Natl. Acad. Sci. USA 90:5021-5025; 1993.
15. Coussens, L.; Yang-Feng, T. L.; Liao, Y. C.; Chen, E.; Gray, A.; McGrath, J.; Seeburg, P. H.; Libermann, T. A.; Schlessinger, J.; Francke, U.; Levinson, A.; Ullrich, A. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230:1132-1139; 1985.
16. Schechter, A. L.; Stern, D. F.; Vaidyanathan, L.; Decker, S. J.; Drebin, J. A.; Greene, M. I.; Weinberg, R. A. The neu oncogene: An erb-B-related gene encoding a 185,000-Mr tumour antigen. Nature 312:513-516; 1984.
17. Fukushige, S.; Matsubara, K.; Yoshida, M.; Sasaki, M.; Suzuki, T.; Semba, K.; Toyoshima, K.; Yamamoto, T. Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line. Mol. Cell. Biol. 6:955-958; 1986.
18. Borg, A.; Tandon, A. K.; Sigurdsson, H.; Clark, G. M.; Ferno, M.; Fuqua, S. A.; Killander, D.; McGuire, W. L. HER-2/neu amplification predicts poor survival in node-positive breast cancer. Cancer Res. 50:4332-4337; 1990.
19. Berchuck, A.; Kamel, A.; Whitaker, R.; Kerns, B.; Olt, G.; Kinney, R.; Soper, J. T.; Dodge, R.; Clarke-Pearson, D. L.; Marks, P.; McKenzie, S.; Yin, S.; Bast, R. C., Jr. Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res. 50:4087-4091; 1990.
20. Kern, J. A.; Schwartz, D. A.; Nordberg, J. E.; Weiner, D. B.; Greene, M. I.; Torney, L.; Robinson, R. A. p185neu expression in human lung adenocarcinomas predicts shortened survival. Cancer Res. 50:5184-5187; 1990.
21. Kapitanovic, S.; Spaventi, R.; Poljak, L.; Kapitanovic, M.; Pavelic, Z. P.; Gluckman, J. L.; Spaventi, S.; Pavelic, K. High c-erbB-2 protein level in colorectal adenocarcinomas correlates with clinical parameters. Cancer Detect. Prev. 18:97-101; 1994.
22. Gum, R.; Wang, S.; Lengyel, E.; Yu, D.; Hung, M.; Juarez, J.; Boyd, D. Up-regulation of urokinase-type plasminogen activator expression by the HER2/neu proto-oncogene. Anticancer Res. 15: 1167-1172; 1995.
23. Backer, J. M.; Mendola, C. E.; Kovesdi, I.; Fairhurst, J. L.; O'Hara, B.; Eddy, R. L., Jr.; Shows, T. B.; Mathew, S.; Murty, V. V. V. S.; Chaganti, R. S. K. Chromosomal localization and nucleoside diphosphate kinase activity of human metastasis-suppressor genes nm23-1 and nm23-2. Oncogene 8:497-502; 1993.
24. Gilles, A. M.; Presecan, E.; Vonica, A.; Lascu, I. Nucleoside diphosphate kinase from human erythrocytes. Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme. J. Biol. Chem. 266:8784-8789; 1991.
25. Steeg, P. S.; Bevilacqua, G.; Kopper, L.; Thorgeirsson, U. P.; Talmadge, J. E.; Liotta, L. A.; Sobel, M. E. Evidence for a novel gene associated with low tumor metastatic potential. J. Natl. Cancer Inst. 80:200-204; 1988.
26. Howlett, A. R.; Petersen, O. W.; Steeg, P. S.; Bissell, M. J. A novel function for the nm23-H1 gene: Overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest. J. Natl. Cancer Inst. 86:1838-1844; 1994.
27. Yang, J.; Ow, K. T.; Russell, P. J.; Ham, J. M.; Crowe, P. J. Higher expression of oncoproteins c-myc, c-erbB-2/neu, PCNA, and p53 in metastasizing colorectal cancer than in non-metastasizing tumors. Ann. Surg. Oncol. 3:574-579; 1996.
28. Berney, C. R.; Yang, J.; Fisher, R. J.; Russell, P. J.; Crowe, P. J. Overexpression of nm23 protein assessed by color video image analysis in metastatic colorectal cancer: Correlation with reduced patient survival. World J. Surg. (in press).
29. Hermanek, P.; Sobin, L. H., eds. UICC. TNM classification of malignant tumours, 4th ed. Berlin: Springer-Verlag; 1992:47-49.
30. Pyke, C.; Ralfkiaer, E.; Ronne, E.; Hoyer-Hansen, G.; Kirkeby, L.; Dano, K. Immunohistochemical detection of the receptor for urokinase plasminogen activator in human colon cancer. Histopathology 24:131-138; 1994.
31. Ganesh, S.; Sier, C. F. M.; Heerding, M. M.; Griffioen, G.; Lamers, C. B. H. W.; Verspaget, H. W. Urokinase receptor and colorectal cancer survival. Lancet 344:401-402; 1994.
32. Blasi, F.; Verde, P. Urokinase-dependent cell surface proteolysis and cancer. Semin. Cancer Biol. 1:117-126; 1990.
33. Duffy, M. J. The role of proteolytic enzymes in cancer invasion and metastasis. Clin. Exp. Metastasis 10:145-155; 1992.
34. Mandai, M.; Konishi, I.; Koshiyama, M.; Mori, T.; Arao, S.; Tashiro, H.; Okamura, H.; Nomura, H.; Hiai, H.; Fukumoto, M. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: Correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression. Cancer Res. 54:1825-1830; 1994.
35. Omori, K. DNA content and c-erbB-2 oncoprotein expression in hepatic metastases from colorectal carcinoma - in relation to clinicopathologic findings and prognosis. J. Jpn. Surg. Soc. 92:1469-1479; 1991.
36. Lazaris, A. C.; Theodoropoulos, G. E.; Anastassopoulos, P.; Nakopoulou, L.; Panoussopoulos, D.; Papadimitriou, K. Prognostic significance of p53 and c-erbB-2 immunohistochemical evaluation in colorectal adenocarcinoma. Histol. Histopathol. 10:661-668; 1995.